![IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice](https://www.mdpi.com/ijms/ijms-22-07380/article_deploy/html/images/ijms-22-07380-g007.png)
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
![Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease](https://www.spandidos-publications.com/article_images/mmr/16/5/MMR-16-05-6184-g01.jpg)
Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease
![Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?](https://www.frontiersin.org/files/Articles/708587/fnins-15-708587-HTML-r2/image_m/fnins-15-708587-g001.jpg)
Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
![Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666354620300259-gr2.jpg)
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
![Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis - ScienceDirect Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383521000915-ga1.jpg)
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis - ScienceDirect
![The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease](https://article.imrpress.com/journal/FBS/14/2/10.31083/j.fbs1402013/1945-0524-14-2-013/fig1.jpg)
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
![Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41401-022-00951-1/MediaObjects/41401_2022_951_Fig1_HTML.png)
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica
![PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons](https://www.researchgate.net/profile/Sandro-Argueelles/publication/221887535/figure/fig2/AS:203178546077698@1425452948203/Interaction-between-glia-and-neurons-may-lead-to-neuron-damage-and-death-LPS-activates_Q320.jpg)
PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
![Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-018-1175-8/MediaObjects/12974_2018_1175_Fig1_HTML.gif)
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
![Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c05837/asset/images/large/ao2c05837_0007.jpeg)
Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega
![Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0197018615000881-nci3712-ga-5001.jpg)
Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect
![Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666354620300259-gr1.jpg)
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
![IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice](https://www.mdpi.com/ijms/ijms-22-07380/article_deploy/html/images/ijms-22-07380-g001.png)
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
![Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease | eNeuro Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease | eNeuro](https://www.eneuro.org/content/9/1/ENEURO.0393-21.2021/F1.large.jpg)
Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease | eNeuro
![IJMS | Free Full-Text | Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats IJMS | Free Full-Text | Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats](https://pub.mdpi-res.com/ijms/ijms-19-00012/article_deploy/html/images/ijms-19-00012-ag.png?1569741565)